Zobrazeno 1 - 10
of 51
pro vyhledávání: '"WHO Grade II Meningioma"'
Autor:
Peng Gao, Tengxiao Kong, Xuqiang Zhu, Yingwei Zhen, Hongjiang Li, Di Chen, Shanpeng Yuan, Dongtao Zhang, Henan Jiao, Xueyuan Li, Dongming Yan
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeThe purpose was to explore the correlation between hematological parameters and the progression of WHO grade II meningioma, and establish a clinical prognostic model based on hematological parameters and clinical prognostic factors to predict
Externí odkaz:
https://doaj.org/article/fb60939fc98a426aaf462b8de02b8b15
Autor:
Taylor Anne Wilson, Lei Huang, Dinesh Ramanathan, Miguel Lopez-Gonzalez, Promod Pillai, Kenneth De Los Reyes, Muhammad Kumal, Warren Boling
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Although the majority of meningiomas are slow-growing and benign, atypical and anaplastic meningiomas behave aggressively with a penchant for recurrence. Standard of care includes surgical resection followed by adjuvant radiation in anaplastic and pa
Externí odkaz:
https://doaj.org/article/55de16915b2c4f9285a0f8621ccf8037
Autor:
Di Chen, Xuqiang Zhu, Tengxiao Kong, Xueyuan Li, Dongming Yan, Hongjiang Li, Shanpeng Yuan, Yingwei Zhen, Dongtao Zhang, Henan Jiao, Peng Gao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
PurposeThe purpose was to explore the correlation between hematological parameters and the progression of WHO grade II meningioma, and establish a clinical prognostic model based on hematological parameters and clinical prognostic factors to predict
Autor:
Lilyana Angelov, Pranay Soni, Varun R. Kshettry, Arbaz Momin, Pablo F. Recinos, Gene H. Barnett, Diana Lopez, Jianning Shao, Alireza M. Mohammadi
Publikováno v:
Journal of Neuro-Oncology. 151:307-312
Clear cell meningioma (CCM) is a rare WHO grade II meningioma variant, characterized by aggressive features and a high tumor recurrence rate. In this study, we compared overall and progression-free survivals between CCMs and other WHO grade II mening
Publikováno v:
Japanese Journal of Neurosurgery. 30:356-364
Autor:
I. Stirban, T. Andrei, A.I. Cucu, B. Dobrovat, Claudia Florida Costea, Mihaela Dana Turliuc, R. Dinu, Gabriela Florenţa Dumitrescu, Camelia Margareta Bogdănici, I. Poeata, Cristina Gena Dascalu, Anca Sava, Ioana Jitaru
Publikováno v:
Romanian Neurosurgery. :52-57
Objective: The objective of our study was to evaluate a possible relation between the volume of atypical meningiomas (AMs) and the risk of tumour recurrence, as well as progression-free survival (PFS). Material and methods: We evaluated 81 patients d
Autor:
Ning Li, Yan Mo, Chencui Huang, Kai Han, Mengna He, Xiaolan Wang, Jiaqi Wen, Siyu Yang, Haoting Wu, Fei Dong, Fenglei Sun, Yiming Li, Yizhou Yu, Minming Zhang, Xiaojun Guan, Xiaojun Xu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundBrain invasion in meningioma has independent associations with increased risks of tumor progression, lesion recurrence, and poor prognosis. Therefore, this study aimed to construct a model for predicting brain invasion in WHO grade II menin
Autor:
Kenneth De Los Reyes, Muhammad Kumal, Dinesh Ramanathan, Promod Pillai, Miguel Angel Lopez-Gonzalez, Lei Huang, Warren Boling, Taylor Anne Wilson
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Although the majority of meningiomas are slow-growing and benign, atypical and anaplastic meningiomas behave aggressively with a penchant for recurrence. Standard of care includes surgical resection followed by adjuvant radiation in anaplastic and pa
Publikováno v:
Neurochirurgie
Neurochirurgie, Elsevier Masson, 2020, 66 (2), pp.73-79. ⟨10.1016/j.neuchi.2019.12.008⟩
Neurochirurgie, Elsevier Masson, 2020, 66 (2), pp.73-79. ⟨10.1016/j.neuchi.2019.12.008⟩
Background Meningioma is the most common primary intracranial tumor, representing 13-36.6% of all primary central nervous system tumors. Meningiomas are benign in about 90% of cases. World Health Organization (WHO) grade II meningioma is associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f62d5a864f76f14a539a5bbf6b01218
https://hal.archives-ouvertes.fr/hal-03468345/file/S0028377020300345.pdf
https://hal.archives-ouvertes.fr/hal-03468345/file/S0028377020300345.pdf
Publikováno v:
Neurochirurgie. 63:273-281
To analyse the outcome of patients with WHO grade II meningioma and identify factors that may influence recurrence and survival.Between January 2000 and October 2016, a retrospective search identified 215 WHO grade II meningiomas operated on at our i